Drug Delivery Beyond Injections
GLP-1 Injection Discontinuation Rates and Their Causes
Most GLP-1 users quit within a year, driven by side effects and weak early feedback on weight loss.
Tobias Wrenfield
· 10 min read
glpletter — Page 8
The Latest
Nose-to-Brain (N2B) Delivery
Olfactory Pathway Anatomy and Drug Transport Mechanisms
Distinguishing two nose-to-brain routes reveals how anatomical design shapes drug targeting.
Tobias Wrenfield